Clinical Trials Browser

Recruiting × Interventional × Immunologic Deficiency Syndromes × Clear all

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Leukopenia, Neutropenia, Warts

NCT06839456 2026-04-15

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Classical hematologyLymphoidOther hematologic neoplasm

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Non-Hodgkin, Metabolism, Inborn Errors

NCT02356653 2026-02-20

ExpMACs

Phase EARLY_PHASE1 Recruiting

100 enrolled

Other hematologic neoplasm

Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome, Bone Marrow Failure Disorders, Immunologic Deficiency Syndromes, Leukemia, Metabolism, Inborn Errors

NCT04554914 2026-02-20

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Phase 2 Recruiting

190 enrolled

LymphoidSarcoma

Immunologic Deficiency Syndromes, Leiomyosarcoma, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT06689800 2025-12-02

Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy

Phase NA Recruiting

60 enrolled

Classical hematologyOther hematologic neoplasm

Anemia, Aplastic, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Metabolic Diseases, Hematologic Neoplasms

NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Phase 1 Recruiting

18 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

NCT06475469 2024-06-26

Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk

Phase NA Recruiting

75 enrolled

LymphoidOther hematologic neoplasm

Bronchiectasis, Immunologic Deficiency Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell

Clinical Trials

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS